Aroa Biosurgery expects to 'more than double' revenue next year
Buying back global rights for wound care product puts NZ biomedical company in the pink.
New Zealand biomedical company Aroa Biosurgery has announced it has bought back the global marketing and distribution rights to its Endoform wound care solutions from US healthcare company Hollister Incorporated.
Hollister bought the rights over a series of transactions that started in 2011 and
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Nick Grant
Thu, 12 Apr 2018
Thu, 12 Apr 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Aroa Biosurgery expects to 'more than double' revenue next year
74429